Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The study aims to compare the novel method of GnRH antagonist administration in the luteal phase versus conventional treatment in IVF patients who develop severe early ovarian hyperstimulation syndrome and have all their embryos cryopreserved.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Eugonia
• Treatments: Cetrorelix

Criteria

Inclusion Criteria:

• Women with established severe early OHSS.

• Criteria for the diagnosis of severe OHSS require:

• the presence of moderate (or higher) ascites and at least two of the following:

• enlarged ovaries (>100 mm maximal diameter),

• haematocrit (Ht) >45%,

• white blood cell count (WBC) >15,000/mm3.

Exclusion Criteria:

• Women not fulfilling the above criteria